Lyn activity protects mice from DSS colitis and regulates the production of IL-22 from innate lymphoid cells

被引:38
作者
Bishop, J. L. [1 ]
Roberts, M. E. [1 ]
Beer, J. L. [1 ]
Huang, M. [1 ]
Chehal, M. K. [1 ]
Fan, X. [1 ]
Fouser, L. A. [2 ]
Ma, H. L. [3 ]
Bacani, J. T. [3 ]
Harder, K. W. [1 ]
机构
[1] Univ British Columbia, Dept Microbiol & Immunol, Res Grp I3, Inst Life Sci, Vancouver, BC V5Z 1M9, Canada
[2] Pfizer Worldwide R&D, Inflammat & Immunol Res Unit, Biotherapeut Res & Dev, Cambridge, MA USA
[3] Univ Alberta, Div Anat Pathol, Dept Lab Med & Pathol, Edmonton, AB, Canada
基金
加拿大健康研究院;
关键词
INFLAMMATORY-BOWEL-DISEASE; COLORECTAL-CANCER; TYROSINE KINASE; CROHNS-DISEASE; SRC-FAMILY; INTESTINAL INFLAMMATION; ULCERATIVE-COLITIS; COMMENSAL BACTERIA; ACTIVATION; MUCOSA;
D O I
10.1038/mi.2013.60
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Intestinal homeostasis requires a complex balance of interactions between diverse resident microbial communities, the intestinal epithelium, and the underlying immune system. We show that the Lyn tyrosine kinase, a critical regulator of immune cell function and pattern-recognition receptor (PRR) responses, has a key role in controlling gastrointestinal inflammation. Lyn(-/-) mice were highly susceptible to dextran sulfate sodium (DSS)-induced colitis, whereas Lyn gain-of-function (Lyn(up)) mice exhibited attenuated colitis during acute and chronic models of disease. Lyn(up) mice were hypersensitive to lipopolysaccharide (LPS), driving enhanced production of cytokines and factors associated with intestinal barrier function, including interleukin (IL)-22. Oral administration of LPS was sufficient to protect antibiotic-treated Lyn(up) but not wild-type mice from DSS, highlighting how Lyn-dependent changes in the nature/magnitude of PRR responses can impact intestinal health. Furthermore, protection from DSS-induced colitis and increased IL-22 production in response to LPS did not depend on the adaptive immune system, with increased innate lymphoid cell-derived IL-22 correlating with Lyn activity in dendritic cells. These data reveal a key role for Lyn in the regulation of innate immune responses and control of intestinal inflammation.
引用
收藏
页码:405 / 416
页数:12
相关论文
共 48 条
[1]   Toll-like receptor signalling in the intestinal epithelium: how bacterial recognition shapes intestinal function [J].
Abreu, Maria T. .
NATURE REVIEWS IMMUNOLOGY, 2010, 10 (02) :131-143
[2]   An innately dangerous balancing act: intestinal homeostasis, inflammation, and colitis-associated cancer [J].
Asquith, Mark ;
Powrie, Fiona .
JOURNAL OF EXPERIMENTAL MEDICINE, 2010, 207 (08) :1573-1577
[3]   Lethal inflammasome activation by a multidrug- resistant pathobiont upon antibiotic disruption of the microbiota [J].
Ayres, Janelle S. ;
Trinidad, Norver J. ;
Vance, Russell E. .
NATURE MEDICINE, 2012, 18 (05) :799-U201
[4]   An agonist of toll-like receptor 5 has radioprotective activity in mouse and primate models [J].
Burdelya, Lyudmila G. ;
Krivokrysenko, Vadim I. ;
Tallant, Thomas C. ;
Strom, Evguenia ;
Gleiberman, Anatoly S. ;
Gupta, Damodar ;
Kurnasov, Oleg V. ;
Fort, Farrel L. ;
Osterman, Andrei L. ;
DiDonato, Joseph A. ;
Feinstein, Elena ;
Gudkov, Andrei V. .
SCIENCE, 2008, 320 (5873) :226-230
[5]  
Chow J, 2010, ADV IMMUNOL, V107, P243, DOI [10.1016/S0065-2776(10)07001-X, 10.1016/B978-0-12-381300-8.00008-3]
[6]   IL-22 is produced by γC-independent CD25+ CCR6+ innate murine spleen cells upon inflammatory stimuli and contributes to LPS-induced lethality [J].
Dumoutier, Laure ;
de Heusch, Magali ;
Orabona, Ciriana ;
Satoh-Takayama, Naoko ;
Eberl, Gerard ;
Sirard, Jean-Claude ;
Di Santo, James P. ;
Renauld, Jean-Christophe .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2011, 41 (04) :1075-1085
[7]   Development and evolution of ROR?t plus cells in a microbe's world [J].
Eberl, Gerard .
IMMUNOLOGICAL REVIEWS, 2012, 245 :177-188
[8]   Carcinogenesis in IBD: potential targets for the prevention of colorectal cancer [J].
Feagins, Linda A. ;
Souza, Rhonda F. ;
Spechler, Stuart J. .
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2009, 6 (05) :297-305
[9]   Increased expression of interleukin 17 in inflammatory bowel disease [J].
Fujino, S ;
Andoh, A ;
Bamba, S ;
Ogawa, A ;
Hata, K ;
Araki, Y ;
Bamba, T ;
Fujiyama, Y .
GUT, 2003, 52 (01) :65-70
[10]   IL-23-responsive innate lymphoid cells are increased in inflammatory bowel disease [J].
Geremia, Alessandra ;
Arancibia-Carcamo, Carolina V. ;
Fleming, Myles P. P. ;
Rust, Nigel ;
Singh, Baljit ;
Mortensen, Neil J. ;
Travis, Simon P. L. ;
Powrie, Fiona .
JOURNAL OF EXPERIMENTAL MEDICINE, 2011, 208 (06) :1127-1133